Fulcrum Therapeutics Company
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.
Founded Date:
2016
Employee Number:
51-100
Funding Status:
IPO
Technology:
Cancer
Industry:
Loss of Proteostasis
Headquarters:
United States
Estimated Revenue:
$1B to $10B